CD274 and non-small cell lung carcinoma: Some meta-analyses [15, 21–25] have investigated that PD-L1 expression was linked to adverse clinicopathological factors and gave the increase of death risk in NSCLC, whereas others drew the opposite conclusions [26, 27].